Jason Cole is the Chief Executive Officer at SalioGen Therapeutics. Previous to his current role, he was at bluebird bio, a pioneering gene, and cell therapy company, where he served in a variety of executive roles, including Chief Strategy & Financial Officer, Chief Business Officer, and Chief Operating & Legal Officer. Prior to joining bluebird in 2014, Jason served as Executive Vice President, Corporate Development, and General Counsel at Zalicus Inc. and as Senior Vice President, General Counsel of Zalicus, and its predecessor company CombinatoRx, Inc. beginning in 2006. From 1999 to 2006, Jason was a corporate and securities attorney at Ropes & Gray LLP. He holds an A.B. in government from Dartmouth College and a J.D. from Columbia University School of Law.